Mark Albrecht, Ph.D.
Biomedical Advanced Research and Development Authority (BARDA)
Mark Albrecht, Ph.D., joined the Biomedical Advanced Research and Development Authority (BARDA) in March 2012. As the chief of the antimicrobials branch, he manages and provides strategic oversight of a complex portfolio of pre-clinical and clinical-stage antimicrobial development programs to advance these candidates through late-stage development to achieve Food and Drug Administration marketing authorization and commercialization.
In addition, Albrecht works across the U.S. government and internationally to strengthen inter-agency collaborations, coordinate efforts and ensure agency portfolios are properly aligned. Before joining BARDA, Albrecht was a senior staff scientist at the Biological Defense Research Directorate (BDRD) within the Naval Medical Research Center (NMRC), where he was responsible for leading the navy’s programs on passive immune therapy and the evaluation of multi-valent/agent vaccination strategies based on recombinant proteins and DNA.
Albrecht received his B.A. in biology from Whitman College in Walla Walla, Wash. and attended the University of California Riverside, where he received his Ph.D. in microbiology for research on the sensitivity and resistance of Pseudomonas aeruginosa and Burkholderia cepacia to antimicrobial peptides and the role of alginate lyase during P. aeruginosa biofilm formation.
In addition, Albrecht works across the U.S. government and internationally to strengthen inter-agency collaborations, coordinate efforts and ensure agency portfolios are properly aligned. Before joining BARDA, Albrecht was a senior staff scientist at the Biological Defense Research Directorate (BDRD) within the Naval Medical Research Center (NMRC), where he was responsible for leading the navy’s programs on passive immune therapy and the evaluation of multi-valent/agent vaccination strategies based on recombinant proteins and DNA.
Albrecht received his B.A. in biology from Whitman College in Walla Walla, Wash. and attended the University of California Riverside, where he received his Ph.D. in microbiology for research on the sensitivity and resistance of Pseudomonas aeruginosa and Burkholderia cepacia to antimicrobial peptides and the role of alginate lyase during P. aeruginosa biofilm formation.